Outcomes of Total Arterial Coronary Artery Bypass Grafting
NCT ID: NCT03231527
Last Updated: 2020-07-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2017-02-01
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Outcome of Total Arterial Revasclarization in IHD
NCT03577821
Use of Various Configurations of Different Arterial Grafts in Total Arterial Revascularization
NCT05300178
Outcome After Coronary Artery Bypass Grafting
NCT02319083
Conservative Non-Invasive Versus Routine Invasive Management in Coronary Artery Bypass Surgery Patients with Non ST Elevation Elevation Acute Coronary Syndrome
NCT01895751
Graft Failure and Consequences of Coronary Artery Bypass Graft Surgery
NCT06800430
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Total Arterial coronary CABG
Total Arterial revascularization
coronary artery bypass grafting (CABG)
myocardial revascularization
Saphenous vein based CABG
Saphenous vein based revascularization
coronary artery bypass grafting (CABG)
myocardial revascularization
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
coronary artery bypass grafting (CABG)
myocardial revascularization
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* concomitant procedures
* redo cases
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Campus Bio-Medico University
OTHER
Universitaire Ziekenhuizen KU Leuven
OTHER
Thorax Centrum Twente
OTHER
Golden Jubilee National Hospital
OTHER_GOV
University of Glasgow
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cristiano Spadaccio
Cardiothoracic surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cristiano Spadaccio, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Golden Jubilee National Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Campus St Ian
Genk, , Belgium
University Campus Bio-Medico
Rome, , Italy
Thoracic Centrum Twente
Enschede, , Netherlands
Golden Jubilee National Hospital
Glasgow, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UG-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.